Fifty three specimens (51 patients) with 5% or more bone marrow hematogones
| Clinical condition . | Number of specimens . |
|---|---|
| Hodgkin lymphoma following treatment | 2 |
| De novo non-Hodgkin lymphoma | 11 |
| Pretreatment | 8 |
| Posttreatment | 3 |
| Non-Hodgkin lymphoma with AIDS | 2 |
| Pretreatment | 1 |
| Posttreatment | 1 |
| HIV/AIDS without lymphoma | 5 |
| Post-chemotherapy for ALL or AML (8 patients) | 9 |
| Post–bone marrow transplantation for AML or MDS | 5 |
| Pretreatment AML (1 patient) | 2 |
| Various nonneoplastic blood cytopenias | 14 |
| Pancytopenia | 4 |
| Neutropenia | 6 |
| Thrombocytopenia | 4 |
| Reactive lymphocytosis | 1 |
| Neuroblastoma | 1 |
| Other (cough, weight loss) | 1 |
| Total specimens | 53 |
| Total patients with NHL4-150 | 13 |
| Total patients with HIV/AIDS4-150 | 7 |
| Total patients post-chemotherapy4-150 | 14 |
| Clinical condition . | Number of specimens . |
|---|---|
| Hodgkin lymphoma following treatment | 2 |
| De novo non-Hodgkin lymphoma | 11 |
| Pretreatment | 8 |
| Posttreatment | 3 |
| Non-Hodgkin lymphoma with AIDS | 2 |
| Pretreatment | 1 |
| Posttreatment | 1 |
| HIV/AIDS without lymphoma | 5 |
| Post-chemotherapy for ALL or AML (8 patients) | 9 |
| Post–bone marrow transplantation for AML or MDS | 5 |
| Pretreatment AML (1 patient) | 2 |
| Various nonneoplastic blood cytopenias | 14 |
| Pancytopenia | 4 |
| Neutropenia | 6 |
| Thrombocytopenia | 4 |
| Reactive lymphocytosis | 1 |
| Neuroblastoma | 1 |
| Other (cough, weight loss) | 1 |
| Total specimens | 53 |
| Total patients with NHL4-150 | 13 |
| Total patients with HIV/AIDS4-150 | 7 |
| Total patients post-chemotherapy4-150 | 14 |
Some of these patients had more than one clinical condition.